PCRX Price Chart
Loading chart...
50 DMA150 DMA200 DMA
PCRXPacira BioSciences, Inc.
$20.65
Financials
AVOID
Investment Thesis
PCRX is a market laggard (RS 28/99, Top 72%) with strong fundamentals. avoid chasing - protect capital. Smart traders skip this one until the setup improves.
Weak relative strength + ordinary growth = Pass
Key Takeaways
- Earnings strong
- RS 28 - market laggard
- No base pattern
- Wait & watch
Earnings Momentum
Earnings Declining
Price Structure
Broken StructurePrice
$20.65
→
50 DMA
$24.33
→
100 DMA
$24.46
✓→
150 DMA
$24.15
→
200 DMA
$24.48
Alignment Score: 1/4
LEADERSHIP TEST FAILED
RS Rating 28/99 is in Bottom 28% of market. Minervini target: Top 20% (RS 80+)
Why Not BUY Yet?
RS Rating
28 (Top 72%)→>80 (Top 20%)
Pattern
No base forming→VCP or constructive base
Trend
Weak Downtrend→Above 200 DMA
What Would Change Our Mind?
To turn bullish on PCRX, we need:
- RS Rating: >80 (Top 20%)(currently 28 (Top 72%))
- Pattern: VCP or constructive base(currently No base forming)
- Trend: Above 200 DMA(currently Weak Downtrend)
Twin Engines Dashboard
Technical Health
RS Rating
28/99
Top 72% (Need 80+)
Trend
Weak Downtrend
Below 200 DMA
RSI (14)
35
WEAK
VCP Setup
COOL
Score: 1/9
Volume
2.5M
+187% vs avg
From Entry
+0.0%
$20.64
Fundamental Horsepower
EPS Qtr YoY
+104%
Growing
EPS 3Y CAGR
N/A
Annual Earnings
Revenue Qtr
+6%
WEAK
F-Score
5/9
Piotroski Quality
ROE
-12%
Return on Equity
EPS Rank
88/99
Percentile
Trade Plan
Stalled BreakoutBreakout Date2025-01-10371 days ago
Entry Was$20.64Breakout price
Gain Since+0%From entry
Reclaim$24.2021 EMA support
If/Then Playbook
IF: RS Rating improves to >80
THEN: Re-evaluate for WATCHLIST
IF: Price closes below 200 DMA
THEN: Remove from radar entirely
IF: EPS growth accelerates to >40% next quarter
THEN: Reassess as potential turnaround
Key Price Levels
Resistance
- 50 DMA$24.33+17.8%
- 200 DMA$24.48+18.5%
- 20 DMA$24.95+20.8%
Current$20.65
Support
- 52W Low$19.84-3.9%
More PCRX Analysis
Frequently Asked Questions
Is PCRX stock a buy now?
PCRX is a market laggard (RS 28/99, Top 72%) with strong fundamentals. avoid chasing - protect capital. Smart traders skip this one until the setup improves.
What is the buy point for PCRX?
PCRX broke out at $20.64 12 month(s) ago but has stalled (flat). Wait for fresh momentum or new base pattern.
What is PCRX's RS Rating?
PCRX has an RS Rating of 28/99, meaning it's in the Top 72% of all stocks for relative price performance over the past 12 months. Minervini recommends RS 80+ for momentum trades.
Important Disclosure: This analysis is for educational and informational purposes only. Technical and fundamental indicators are based on historical data and do not guarantee future performance. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.